Each name scored against its own layer of true peers on five fundamentals-led axes, a long-term entry tool for 1 to 5 year holds, not a trading signal.
The peace-deal side of the ledger gained a third independent voice with a believable political motive: the analysts at Forward Guidance argue the administration is deliberately engineering de-escalation with Iran to protect the SpaceX stock offering and avoid +80% gasoline prices before the midterm elections — and that demand destruction from high prices is underappreciated. Trump has declared the war over (Iran denies anything is final; the stated red lines remain unmet). But the physical tail risk is undiminished if talks fail: the Strait of Hormuz — the channel carrying a fifth of the world's oil — remains shut, US diesel inventories sit at 23-year lows, and losing the region's 13-14 million barrels per day would empty global storage by August-September. Too early to add; favor the cash-generating end of the sector (refiners, large producers).
Every company is scored only against its true peer group on four axes — Value (price vs earnings), Quality (profitability, debt), Trend (price momentum), Analysts (Wall Street view). Green letters = strong vs peers, red = weak. SCREEN+ means top of its peer group and SCREEN− bottom — these are research rankings that flag where to look next, not buy or sell orders. Click any company row for a plain-English read.
| # | Name | Screen | Score | Axes V·Q·T·A | Roster | Price | Valuation | |
|---|---|---|---|---|---|---|---|---|
| 1 | AR | SCREEN+ | +1.84 | VQTA | · | $34.91 +2.0% | 7× EBITDA +16% FCF · 2.8× sales · Fwd P/E 7× |
⌄ |
Screen+ (top of cohort): fairly valued, average quality, mid-trend, analysts bullish — top of its layer. Quality ROIC 6% ND/EBITDA 2.2 · Trend 200d -1% · 52w 33% · RS1y -47% · Analysts upside +46% · rating +0.70 | ||||||||
| 2 | EQT | +0.16 | VQTA | · | $52.16 +1.9% | 5× EBITDA +12% FCF · 3.8× sales · Fwd P/E 11× |
⌄ | |
Mid-cohort: fairly valued, average quality, on an attractive pullback, analysts cautious. Quality ROIC 9% ND/EBITDA 0.7 · Trend 200d -8% · 52w 16% · RS1y -40% · Analysts upside -21% · rating +0.67 | ||||||||
| 3 | XOM | -0.29 | VQTA | · | $148.53 +1.3% | 11× EBITDA +3% FCF · 2.0× sales · Fwd P/E 14× |
⌄ | |
Mid-cohort: fairly valued, average quality, mid-trend, analysts cautious. Quality ROIC 5% ND/EBITDA 0.6 · Trend 200d +11% · 52w 65% · RS1y +2% · Analysts upside +15% · rating +0.35 | ||||||||
| 4 | OXY | SCREEN− | -0.68 | VQTA | · | $57.04 +2.8% | 6× EBITDA +6% FCF · 3.0× sales · Fwd P/E 15× |
⌄ |
Screen− (bottom of cohort): fairly valued, average quality, mid-trend, analysts cautious. Quality ROIC 3% ND/EBITDA 1.0 · Trend 200d +16% · 52w 66% · RS1y -6% · Analysts upside +9% · rating +0.40 | ||||||||
| 5 | OVV | SCREEN− | -1.02 | VQTA | · | $57.56 +1.8% | 9× EBITDA +24% FCF · 2.7× sales · Fwd P/E 7× |
⌄ |
Screen− (bottom of cohort): fairly valued, weak quality, mid-trend. Quality ROIC 2% ND/EBITDA 2.8 · Trend 200d +23% · 52w 80% · RS1y +8% · Analysts upside +14% · rating +0.77 | ||||||||
| # | Name | Screen | Score | Axes V·Q·T·A | Roster | Price | Valuation | |
|---|---|---|---|---|---|---|---|---|
| 1 | RRC | SCREEN+ | +0.95 | VQTA | · | $38.75 +2.0% | 7× EBITDA +14% FCF · 3.2× sales · Fwd P/E 8× |
⌄ |
Screen+ (top of cohort): fairly valued, average quality, mid-trend, analysts cautious — top of its layer. Quality ROIC 11% ND/EBITDA 0.6 · Trend 200d +0% · 52w 40% · RS1y -37% · Analysts upside +22% · rating +0.37 | ||||||||
| 2 | MGY | SCREEN+ | +0.91 | VQTA | · | $27.83 +2.2% | 6× EBITDA +7% FCF · 4.1× sales · Fwd P/E 11× |
⌄ |
Screen+ (top of cohort): fairly valued, high quality, mid-trend. Quality ROIC 13% ND/EBITDA 0.3 · Trend 200d +8% · 52w 59% · RS1y -16% · Analysts upside +6% · rating +0.54 | ||||||||
| 3 | SM | -0.40 | VQTA | · | $31.91 +2.0% | 7× EBITDA -3% FCF · 3.7× sales · Fwd P/E 4× |
⌄ | |
Mid-cohort: fairly valued, average quality, extended or lagging, analysts cautious. Quality ROIC -8% ND/EBITDA 3.1 · Trend 200d +30% · 52w 83% · RS1y -16% · Analysts upside +10% · rating +0.52 | ||||||||
| 4 | TALO | SCREEN− | -1.45 | VQTA | · | $15.19 +2.6% | 9× EBITDA +13% FCF · 2.0× sales · Fwd P/E 610× |
⌄ |
Screen− (bottom of cohort): expensive vs peers, weak quality, on an attractive pullback, analysts bullish. Quality ROIC -7% ND/EBITDA 2.2 · Trend 200d +24% · 52w 84% · RS1y +33% · Analysts upside +18% · rating +0.54 | ||||||||
| # | Name | Screen | Score | Axes V·Q·T·A | Roster | Price | Valuation | |
|---|---|---|---|---|---|---|---|---|
| 1 | VLO | SCREEN+ | +1.21 | VQTA | · | $258.92 +1.3% | 9× EBITDA +8% FCF · 0.7× sales · Fwd P/E 12× |
⌄ |
Screen+ (top of cohort): fairly valued, average quality, mid-trend — top of its layer. Quality ROIC 10% ND/EBITDA 0.6 · Trend 200d +30% · 52w 97% · RS1y +60% · Analysts upside -6% · rating +0.59 | ||||||||
| 2 | MPC | +0.03 | VQTA | · | $266.24 +2.1% | 9× EBITDA +7% FCF · 0.8× sales · Fwd P/E 11× |
⌄ | |
Mid-cohort: fairly valued, average quality, extended or lagging. Quality ROIC 9% ND/EBITDA 2.6 · Trend 200d +29% · 52w 99% · RS1y +28% · Analysts upside -9% · rating +0.76 | ||||||||
| 3 | DK | SCREEN− | -1.24 | VQTA | · | $48.02 +2.0% | 8× EBITDA +16% FCF · 0.5× sales · Fwd P/E 21× |
⌄ |
Screen− (bottom of cohort): cheap vs peers, weak quality, on an attractive pullback. Quality ROIC -8% ND/EBITDA 3.7 · Trend 200d +29% · 52w 96% · RS1y +104% · Analysts upside -2% · rating +0.31 | ||||||||
| # | Name | Screen | Score | Axes V·Q·T·A | Roster | Price | Valuation | |
|---|---|---|---|---|---|---|---|---|
| 1 | DHT | SCREEN+ | +1.88 | VQTA | · | $17.12 +2.8% | 7× EBITDA -5% FCF · 5.5× sales · Fwd P/E 9× |
⌄ |
Screen+ (top of cohort): fairly valued, high quality, mid-trend, analysts cautious — top of its layer. Quality ROIC 16% ND/EBITDA 0.8 · Trend 200d +15% · 52w 72% · RS1y +13% · Analysts upside +5% · rating +0.50 | ||||||||
| 2 | KGS | +0.39 | VQTA | · | $69.54 +3.6% | 10× EBITDA +3% FCF · 5.3× sales · Fwd P/E 23× |
⌄ | |
Mid-cohort: expensive vs peers, high quality, extended or lagging, analysts bullish. Quality ROIC 8% ND/EBITDA -0.1 · Trend 200d +47% · 52w 86% · RS1y +70% · Analysts upside +21% · rating +0.89 | ||||||||
| 3 | BORR | +0.20 | VQTA | · | $4.67 +0.3% | 8× EBITDA -10% FCF · 3.1× sales · Fwd P/E 17× |
⌄ | |
Mid-cohort: fairly valued, weak quality, on an attractive pullback. Quality ROIC 4% ND/EBITDA 4.9 · Trend 200d +6% · 52w 60% · RS1y +80% · Analysts upside +22% · rating +0.00 | ||||||||
| 4 | NE | -0.42 | VQTA | · | $46.92 +1.7% | 8× EBITDA +6% FCF · 2.7× sales · Fwd P/E 16× |
⌄ | |
Mid-cohort: fairly valued, average quality, mid-trend, analysts cautious. Quality ROIC 6% ND/EBITDA 1.1 · Trend 200d +23% · 52w 74% · RS1y +28% · Analysts upside -2% · rating +0.06 | ||||||||
| 5 | PDS | SCREEN− | -0.91 | VQTA | · | $97.04 +0.6% | 5× EBITDA +8% FCF · 1.3× sales · Fwd P/E 8× |
⌄ |
Screen− (bottom of cohort): cheap vs peers, weak quality, mid-trend. Quality ROIC -4% ND/EBITDA 1.4 · Trend 200d +27% · 52w 91% · RS1y +61% · Analysts upside +17% · rating +0.46 | ||||||||
| 6 | AROC | SCREEN− | -1.14 | VQTA | · | $36.90 +2.3% | 10× EBITDA +4% FCF · 5.8× sales · Fwd P/E 17× |
⌄ |
Screen− (bottom of cohort): expensive vs peers, average quality, mid-trend. Quality ROIC 9% ND/EBITDA 2.7 · Trend 200d +23% · 52w 84% · RS1y +14% · Analysts upside +15% · rating +0.83 | ||||||||
| # | Name | Screen | Score | Axes V·Q·T·A | Roster | Price | Valuation | |
|---|---|---|---|---|---|---|---|---|
| 1 | XOP ETF | SCREEN+ | +1.60 | VQTA | · | $166.74 +2.0% | ETF — price only | ⌄ |
Price-only ETF (no fundamentals); on trend it is middling. Trend 200d +14% · 52w 68% · RS1y -5% | ||||||||
| 2 | XLE ETF | SCREEN+ | +0.65 | VQTA | · | $57.90 +1.4% | ETF — price only | ⌄ |
Price-only ETF (no fundamentals); on trend it is middling. Trend 200d +14% · 52w 77% · RS1y +0% | ||||||||
| 3 | XES ETF | -0.40 | VQTA | · | $124.44 +1.3% | ETF — price only | ⌄ | |
Price-only ETF (no fundamentals); on trend it is middling. Trend 200d +28% · 52w 87% · RS1y +49% | ||||||||
| 4 | PSCE ETF | SCREEN− | -0.63 | VQTA | · | $60.45 +1.9% | ETF — price only | ⌄ |
Price-only ETF (no fundamentals); on trend it is middling. Trend 200d +20% · 52w 86% · RS1y +15% | ||||||||
| 5 | USO ETF | SCREEN− | -1.21 | VQTA | · | $128.74 -0.1% | ETF — price only | ⌄ |
Price-only ETF (no fundamentals); on trend it is middling. Trend 200d +38% · 52w 72% · RS1y +38% · Analysts upside +96% | ||||||||